Ledger.Open graph →
SEC Form D · Amendment · filed June 15, 2021

Vigil Neuroscience, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Clay Thorp · Malvern, PADirectorGerhard Koenig · Cambridge, MADirectorBruce Booth · Cambridge, MADirectorBruce Booth · Waltham, MADirectorGerhard Koenig · Cambridge, MADirectorIvana Magovcevic-Liebisch · Cambridge, MAExec · DirectorShaan Gandhi · Durham, NCDirectorCheryl Blanchard · Woburn, MADirectorCheryl Blanchard · Woburn, MADirectorShaan Gandhi · Durham, NCDirectorClay Thorp · Nashville, TNDirectorIvana Magovcevic-Liebisch · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗